ALFRED LIDDLE: Open Payments
NPI 1205813615 · LINCOLN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,741 in 145 payments from 24 companies in 2025. Trend: 2023 $4,987 · 2024 $4,596 · 2025 $4,741
Food & beverage: $4,741
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 30 | $1,082 |
| ABBVIE INC. | 28 | $991 |
| Abbott Laboratories | 8 | $481 |
| Amgen Inc. | 12 | $357 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $338 |
| Lilly USA, LLC | 10 | $216 |
| Actelion Pharmaceuticals US, Inc. | 2 | $152 |
| Exact Sciences Corporation | 8 | $144 |
| Novo Nordisk Inc | 6 | $142 |
| PFIZER INC. | 4 | $141 |
Products named: VRAYLAR, AIRSUPRA, FREESTYLE LIBRE 3, JARDIANCE, BREZTRI, FARXIGA, UBRELVY, EVENITY.
Industry payments across RI — which companies pay providers there.
